These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6087329)

  • 41. Heterozygous mutation in the G+5 position of intron 33 of the pro-alpha 2(I) gene (COL1A2) that causes aberrant RNA splicing and lethal osteogenesis imperfecta. Use of carbodiimide methods that decrease the extent of DNA sequencing necessary to define an unusual mutation.
    Ganguly A; Baldwin CT; Strobel D; Conway D; Horton W; Prockop DJ
    J Biol Chem; 1991 Jun; 266(18):12035-40. PubMed ID: 1711048
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduced secretion of structurally abnormal type I procollagen in a form of osteogenesis imperfecta.
    Barsh GS; Byers PH
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5142-6. PubMed ID: 6946461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The phenotypic features of osteogenesis imperfecta resulting from a mutation of the carboxyl-terminal pro alpha 1 (I) propeptide that impairs the assembly of type I procollagen and formation of the extracellular matrix.
    Cole WG; Chow CW; Bateman JF; Sillence DO
    J Med Genet; 1996 Nov; 33(11):965-7. PubMed ID: 8950680
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Altered triple helical structure of type I procollagen in lethal perinatal osteogenesis imperfecta.
    Bonadio J; Holbrook KA; Gelinas RE; Jacob J; Byers PH
    J Biol Chem; 1985 Feb; 260(3):1734-42. PubMed ID: 2981871
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gly802Asp substitution in the pro alpha 2(I) collagen chain in a family with recurrent osteogenesis imperfecta due to paternal mosaicism.
    Lund AM; Schwartz M; Raghunath M; Steinmann B; Skovby F
    Eur J Hum Genet; 1996; 4(1):39-45. PubMed ID: 8800927
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutation in the carboxy-terminal propeptide of the Pro alpha 1(I) chain of type I collagen in a child with severe osteogenesis imperfecta (OI type III): possible implications for protein folding.
    Oliver JE; Thompson EM; Pope FM; Nicholls AC
    Hum Mutat; 1996; 7(4):318-26. PubMed ID: 8723681
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Type I procollagen: the gene-protein system that harbors most of the mutations causing osteogenesis imperfecta and probably more common heritable disorders of connective tissue.
    Prockop DJ; Constantinou CD; Dombrowski KE; Hojima Y; Kadler KE; Kuivaniemi H; Tromp G; Vogel BE
    Am J Med Genet; 1989 Sep; 34(1):60-7. PubMed ID: 2683782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disruption of one intra-chain disulphide bond in the carboxyl-terminal propeptide of the proalpha1(I) chain of type I procollagen permits slow assembly and secretion of overmodified, but stable procollagen trimers and results in mild osteogenesis imperfecta.
    Pace JM; Kuslich CD; Willing MC; Byers PH
    J Med Genet; 2001 Jul; 38(7):443-9. PubMed ID: 11432962
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A 5' splice site mutation affecting the pre-mRNA splicing of two upstream exons in the collagen COL1A1 gene. Exon 8 skipping and altered definition of exon 7 generates truncated pro alpha 1(I) chains with a non-collagenous insertion destabilizing the triple helix.
    Bateman JF; Chan D; Moeller I; Hannagan M; Cole WG
    Biochem J; 1994 Sep; 302 ( Pt 3)(Pt 3):729-35. PubMed ID: 7945197
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Substitution of cysteine for glycine-946 in the alpha 1(I) chain of type I procollagen causes lethal osteogenesis imperfecta.
    Kurosaka D; Hattori S; Hori H; Yamaguchi N; Hasegawa T; Akimoto H; Nagai Y
    J Biochem; 1994 May; 115(5):853-7. PubMed ID: 7961597
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutations linked to the pro alpha 2(I) collagen gene are responsible for several cases of osteogenesis imperfecta type I.
    Wallis G; Beighton P; Boyd C; Mathew CG
    J Med Genet; 1986 Oct; 23(5):411-6. PubMed ID: 3023615
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A defect in the structure of type I procollagen in a patient who had osteogenesis imperfecta: excess mannose in the COOH-terminal propeptide.
    Peltonen L; Palotie A; Prockop DJ
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6179-83. PubMed ID: 6934545
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Production of overmodified type I procollagen in a case of osteogenesis imperfecta.
    Tajima S; Takehana M; Azuma N
    J Dermatol; 1994 Apr; 21(4):219-22. PubMed ID: 8056893
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An intronic deletion leading to skipping of exon 21 of COL1A2 in a boy with mild osteogenesis imperfecta.
    Superti-Furga A; Raghunath M; Pistone FM; Romano C; Steinmann B
    Connect Tissue Res; 1993; 29(1):31-40. PubMed ID: 8339544
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Altered helical structure of a homotrimer of alpha 1(I)chains synthesized by fibroblasts from a variant of osteogenesis imperfecta.
    Deak SB; van der Rest M; Prockop DJ
    Coll Relat Res; 1985 Sep; 5(4):305-13. PubMed ID: 4053561
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lethal osteogenesis imperfecta resulting from a single nucleotide change in one human pro alpha 1(I) collagen allele.
    Cohn DH; Byers PH; Steinmann B; Gelinas RE
    Proc Natl Acad Sci U S A; 1986 Aug; 83(16):6045-7. PubMed ID: 3016737
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SSCP detection of a Gly565Val substitution in the pro alpha 1(I) collagen chain resulting in osteogenesis imperfecta type II.
    Mackay K; Lund AM; Raghunath M; Steinmann B; Dalgleish R
    Hum Genet; 1993 Jun; 91(5):439-44. PubMed ID: 8100209
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular basis of osteogenesis imperfecta and related disorders of bone.
    Prockop DJ; Kuivaniemi H; Tromp G
    Clin Plast Surg; 1994 Jul; 21(3):407-13. PubMed ID: 7924138
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical variability of osteogenesis imperfecta linked to COL1A2 and associated with a structural defect in the type I collagen molecule.
    Superti-Furga A; Pistone F; Romano C; Steinmann B
    J Med Genet; 1989 Jun; 26(6):358-62. PubMed ID: 2567784
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lethal perinatal osteogenesis imperfecta due to a type I collagen alpha 2(I) Gly to Arg substitution detected by chemical cleavage of an mRNA:cDNA sequence mismatch.
    Bateman JF; Moeller I; Hannagan M; Chan D; Cole WG
    Hum Mutat; 1992; 1(1):55-62. PubMed ID: 1284475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.